The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain.
Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.
A second study presented at IDWeek showed that shingles vaccination decreases the risk for death and heart disease — this time among people living with HIV.“Shingles is usually thought of as a painful ...
ScienceAlert on MSN
HIV's Cunning Strategy For Hiding in Our Body Finally Revealed
According to the new study, HIV achieves this with a tissue-specific approach, cloaking itself in a host cell's DNA by ...
Morning Overview on MSN
Researchers make major progress toward curing HIV
On October 20, 2025, scientists announced a significant advancement toward curing HIV, marking a pivotal moment in the ...
The challenge with curing the Human Immunodeficiency Virus (HIV) is that it tends to hide dormant in cells, evading the ...
Rift Valley Fever (RVF) is a viral disease transmitted by mosquitoes that mainly affects livestock. It can also infect humans ...
There was no significant difference in virologic efficacy through 96 weeks in adults with HIV who switched to DTG/3TC vs continued BIC/FTC/TAF.
BIC/TAF/FTC demonstrated a stronger long-term immunologic response than DTG/TDF/FTC in patients with HIV who had low CD4+ counts.
Ebola is one of the nasty viruses that can hide in the body even after a patient recovers and tests negative. It can reemerge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback